BrainReference is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.
We aim to provide consumers with helpful, in-depth information about brain health products. Whether we make money or not on a certain page does not influence the core mission of our writers and medical reviewers, which is to publish content that is accurate and informative.
All product names, logos, and brands are the property of their respective owners.
For more information, see our full Advertising Disclosure
Mydayis Review – 14 Things You Should Know
Mydayis (brand name) is a stimulant prescription medication used to treat attention deficit hyperactivity disorder (ADHD) in adults and children ages 13 years and older.
ADHD is a multifaceted neurodevelopmental disorder that can affect a child’s relationships and success at school. There are no apparent symptoms of ADHD, making this disorder hard to recognize in many cases.
Any child may undergo many of the individual symptoms of attention deficit hyperactivity disorder. ADHD is usually diagnosed in children by the time they’re adolescents, with the average age for moderate ADHD diagnosis being seven years.
1) What is Mydayis?
Mydayis is a stimulant prescription medication that contains a mixture of four amphetamine salts: dextroamphetamine saccharate, dextroamphetamine sulfate, amphetamine aspartate monohydrate, and amphetamine sulfate.
Mydayis belongs to a class of medications called stimulants. The formulation is similar to Adderall’s formula and contains four amphetamine salts called “mixed amphetamine salts.” Mydayis is available in an extended-release capsule taken orally.
Extended-release drugs gradually enter your bloodstream so that you have a constant level of the drug in your body all day.
Please note that Mydayis is a black box classified drug. This is the most severe warning from the Food and Drug Administration (FDA), and it warns physicians and patients about the drug being potentially dangerous or highly addictive.
The four amphetamine salts found in Mydayis’ formula are powerful stimulants that can potentially be abused if not taken as prescribed. This may lead to high blood pressure, a fast heart rate, aggressive behavior, anxiety, and in rare cases, early death.
2) The Company Behind Mydayis
The FDA approved Mydayis (mixed salts of a single-entity amphetamine product) for the treatment of ADHD in 2017. For the United States, this prescription drug is made by Shire Pharmaceuticals.
Shire Pharmaceuticals is a Jersey-registered specialty biopharmaceutical company. Originating in the United Kingdom with headquarters in the United States, its brands and products include popular prescription drugs such as Adderall XR, Lialda, and Vyvanse. Takeda Pharmaceutical Company acquired Shire Pharmaceuticals and all its patents on January 8, 2019.
Shire Pharmaceuticals LLC contact information:
- Phone: +1 617 349 0200 (United States) / +41 0 41 288 40 00 (Internationally)
- Address: 300 Shire Way, Lexington, MA 02421, United States;
- Website: shire.com
3) Ingredients of Mydayis
Mydayis contains the following active ingredients:
- Dextroamphetamine saccharate
- Dextroamphetamine sulfate
- Amphetamine sulfate
- Amphetamine aspartate monohydrate.
4) What Does Mydayis Do?
Two Cochrane reviews on the treatment of ADD/ADHD in subjects of all ages with pharmaceutical amphetamines asserted that short-term studies have demonstrated that these drugs decrease the severity of symptoms. Still, they have higher discontinuation rates than non-stimulant medications due to their adverse side effects.
Another Cochrane review on the prescription of ADD/ADHD in children with tic disorders such as Tourette Syndrome showed that stimulants, in general, do not make tics worse. Nevertheless, large doses of dextroamphetamine could worsen spasms in some patients.
Several clinical reviews and studies confirmed the effectiveness and safety of long-term, uninterrupted amphetamine salts used to treat ADD/ADHD. Long-term continuous stimulant therapy for ADHD is effective for enhancing the quality of life and academic achievement, reducing the core symptoms of ADHD (i.e., impulsivity, inattention, and hyperactivity).
This form of therapy is also effective at producing improvements in a large number of functional outcomes across nine categories of results related to antisocial behavior, academics, non-medicinal drug use, driving, obesity, self-esteem, occupation, social function, and service use (i.e., occupational, academic, financial, health, and legal services).
Dextroamphetamine and amphetamine are central nervous system stimulants. They impact chemicals in nerves and in the brain that contribute to hyperactivity and impulse control.
In each of the five studies, patients with ADHD were given either Mydayis or a placebo. Each study included adults as well as teenagers ages 13 years and older.
All participants were assessed with ADHD rating scales at the start of each study and throughout to measure how their symptoms progress or ease.
At the end of each study, ADHD symptoms had lessened significantly in the patients who took Mydayis correlated to those participants who were given a placebo.
5) Mydayis Claims
Mydayis claimed benefits include:
- Once-daily treatment that lasts up to 16 hours after dosing;
- Provides improved attention in ADHD up to 16 hours after dosing;
- The first ADHD treatment to offer triple-bead delivery for the extended-release of medication;
- Safer than other similar prescription drugs.
6) Potential Mydayis Adverse Effects
- Dry mouth
- Feeling jittery or anxious
- Reduced appetite
- Feeling restless
- Irregular or painful periods
- Erectile dysfunction
- Weight loss
Serious side effects from Mydayis aren’t common, but they can occur. Serious side effects of Mydayis may include the following:
- Risk of stunted growth in children and teenagers
- High blood pressure
- Heart palpitations (feeling of skipped or extra heartbeats)
- Loss of awareness or consciousness
- Rapid heartbeat
- Heart attack
- Aggressive behavior
- Jerking movements of the arms and legs
- Impaired and delusional thinking
- Cold or blue-colored fingers and toes
- Agitated or irritable behavior
- Temporary confusion
- Random pain or tingling in the fingers and toes
7) What You Need to Know Before Taking Mydayis
While Mydayis is advertised as a less dangerous prescription drug, it may still interact with several other prescription drugs. Do not take Mydayis if you are already taking one of the following medicines:
- Abilify (aripiprazole)
- Klonopin (clonazepam)
- Prozac (fluoxetine)
- Trintellix (vortioxetine)
- Vyvanse (lisdexamfetamine)
- Zyrtec (cetirizine)
- Singulair (montelukast)
- Xanax (alprazolam)
- Cymbalta (duloxetine)
- Lamictal (lamotrigine)
If you’re planning about becoming pregnant, discuss the use of Mydayis with your physician. Animal studies indicate a potential risk of fetal harm. Infants may be born with low birth weight, prematurely, have motor or learning deficits, or experience withdrawal. Mydayis is passed through breastmilk, so it is recommended that mothers do not nurse while taking it.
8) Where to Buy Mydayis?
As a prescription drug, Mydayis can be purchased from most pharmacies across the United States.
Shire Pharmaceuticals offers a small discount in the form of a discount card on your phone. Simply take it to the pharmacy with your prescription and save between $30 and $60 on each refill.
9) How Much Does Mydayis Cost?
The price for Mydayis oral tablet, extended-release 12.5 mg, can reach $1,028 for a supply of 100 tablets (up to $10,28 per tablet). A generic version of Mydayis is available in the form of an amphetamine and dextroamphetamine mixture.
10) What Are Mydayis Alternatives?
Because Mydayis is a prescription drug, we can only review other prescription medicines as potential alternatives. We don’t advocate substituting a treatment directed by your physician with an over-the-counter dietary supplement.
Concerta (Methylphenidate) is a controlled substance used to treat attention deficit hyperactivity disorder (ADHD). It works by activating the areas of your brain that are responsible for paying attention and staying focused.
Concerta is available as an extended-release tablet in various strengths: 18 mg, 27 mg, 36 mg, and 54 mg.
Vyvanse is a brand name for a drug that contains lisdexamfetamine. When lisdexamfetamine enters the body, it is changed to dextroamphetamine. Vyvanse is available in one formula and is effective for approximately 14 hours.
The FDA approved this prescription drug in 2007 and is prescribed to treat people six years and older. In addition to treating ADD/ADHD, lisdexamfetamine can also be prescribed to treat binge eating disorder.
Adderall is considered a first-choice treatment option for ADHD. Studies show that it improves attention, focus, and reduces impulsive behaviors. Between 75% and 80% of children with ADD/ADHD will see improved symptoms with the use of stimulant prescription drugs. Adderall is also a valid option for increasing daytime wakefulness in individuals with narcolepsy, although there is little related research.
11) How to Take Mydayis
For teens, the recommended starting dose for Mydayis is 12.5 mg once daily in the morning. For adult patients, this prescription drug is available in four strengths: 12.5 mg, 25 mg, 37.5 mg, 50 mg.
12) Of the Same Product Line
Mydayis comes as an extended-release capsule, and it’s available in four strengths: two strengths for teens (12.5 mg and 25 mg) and two strengths for adults (37.5 mg and 50 mg).
13) Mydayis Reviews
"I've been taking meds for ADHD/ADD close to 8 years now. Tried Adderall at many dosages, types, and amounts of times per day over many years. My biggest issue. I forgot to take them. I tried Vyvanse." [Read full review]
"I asked my doctor about Mydayis because it lasts 16 hours. The first week I was so calm, never been so calm in my life, even with antidepressants. I was able to focus on conversations." [Read full review]
"I am diagnosed with Concurrent Concussion Syndrome with ADD symptoms. I took Vyvanse for over a year, and I thought I loved it until I realized it gave me anxiety because I was trying to cram 16 hours' worth of homework and chores into the short period the medication worked. " [Read full review]
14) The Bottom Line – “Does it Work?”
Mydayis includes the same active ingredients as Shire’s well-known ADD/ADHD prescription medication Adderall but is formulated to help alleviate symptoms for up to 16 hours post-dose.
While ADD/ADHD is more commonly thought of in childhood or adolescence, Mydayis is targeted more towards adult patients. In essence, a group Shire Pharmaceuticals pegs as the fastest-growing segment of the ADHD market.It's important to remember brain supplementation is not one size fits all, Mydayis is formulated to address specific brain health needs, if your needs differ, consider other products.
An excellent brain supplement for calm and focus is HCF® Happy, Calm & Focused. Trusted for over 10 years with the highest quality, simple, clean ingredients for effectively nourishing the brain, HCF Science has been dedicated to only the foundational building blocks of life; amino acids, minerals, and vitamins, unlike the common high-dose 'all-in-one' or artificially stimulating/inhibiting nootropics found on the market today for supporting calm and focus.
|Mydayis Customers Also Shopped:||
10+ Yrs Proven
|HCF Happy, Calm & Focused
Mydayis Questions & Answers
Mydayis contains the following active ingredients: dextroamphetamine saccharate, dextroamphetamine sulfate, amphetamine sulfate, and amphetamine aspartate monohydrate.
Mydayis produced by Shire Pharmaceuticals is a stimulant prescription drug used to treat attention deficit hyperactivity disorder (ADHD) in adults as well as children ages 13 years and older.
Mydayis can cause mild, moderate, and severe side effects, including depression, heart palpitations, loss of awareness or consciousness, rapid heartbeat, stroke, heart attack, aggressive behavior, agitated or irritable behavior, temporary confusion, insomnia, dry mouth, feeling jittery or anxious, reduced appetite, feeling restless, irregular or painful periods, erectile dysfunction, weight loss, diarrhea, and high blood pressure.
As a prescription medication, Mydayis is available for purchase at most pharmacies.
The price for Mydayis oral tablet, extended-release 12.5 mg, can reach $1,028 for a supply of 100 tablets (up to $10,28 per pill).
Mydayis is a once-daily treatment that lasts up to 16 hours after dosing. According to Shire Pharmaceuticals, this is the first ADHD treatment to offer triple-bead delivery for the extended-release medication.
Mydayis was not designed to enhance brain functions but to regulate chemicals responsible for impulse control and hyperactivity.
As with all prescription medication, we advise caution when taking Mydayis with other prescription meds or over-the-counter dietary supplements. Drugs that may interact with Mydayis include Zyrtec (cetirizine), Bupropion, Singulair (montelukast), Clonazepam, Xanax (alprazolam), Cymbalta (duloxetine), Gabapentin, Trazodone, Lamictal (lamotrigine), Lamotrigine, Levothyroxine, Abilify (aripiprazole), Propranolol, Klonopin (clonazepam), Prozac (fluoxetine), Spironolactone, Trintellix (vortioxetine), Vyvanse (lisdexamfetamine), and Buspirone.
Please note that many other prescription medications may affect the way Mydayis works. The drug could also affect other medicines. It's imperative to let your physician know about everything you are taking before starting a treatment with this prescription drug. Potential dangerous interactions include any over-the-counter (OTC) medications, herbs, dietary supplements, and illegal drugs.
Yes, Mydayis can be prescribed to children and adolescents age 13 and older.
Mydayis contains a mixture of four amphetamine salts. These substances were tested across multiple clinical trials and shown to cause mild, moderate, and even severe side effects in some patients.
You should not be taking Mydayis unless it was prescribed to you by a physician.
Pregnant or nursing women should discuss with a medical doctor before taking Mydayis. As with all prescription drugs, this one may also have a potential risk of fetal harm.
For teens, the recommended starting dose for Mydayis is 12.5 mg once daily in the morning. For adult patients, this prescription drug is available in four strengths: 12.5 mg, 25 mg, 37.5 mg, 50 mg.
You can contact the Shire Pharmaceuticals LLC customer support department by phone at +1 617 349 0200, by mail at 300 Shire Way, Lexington, MA 02421, United States, or by using the Contact Us form available on their official website.
As Mydayis is a prescription medication, please discuss any possible returns or refunds with the doctor who prescribed it.
Most complaints gravitate around Mydayis' potential side effects and the many likely interactions with other prescription drugs or dietary supplements. Some users have also complained about a lack of results when taking this medicine.
Mydayis' reviews are mixed. On drugs.com (the leading authority for prescription drugs information), this prescription medicine has an average rating of 5.5 out of 10 (ADD/ADHD).
Mydayis is produced and marketed by U.S.-based Shire Pharmaceuticals.
- Official MyDayis website - mydayis.com. Retrieved on April 7, 2021.
- Mydayis - accessdata.fda.gov. Retrieved on April 7, 2021.
- A Guide to Drug Safety Terms at FDA - fda.gov. Retrieved on April 7, 2021.
- Shire plc: US FDA Approves Mydayis (Mixed Salts of a Single-Entity Amphetamine Product) - A New Once-Daily Option for ADHD Symptom Control in Patients 13 Years and Older. prnewswire.com. Published on June 20, 2017. Retrieved on April 7, 2021.
- Official Shire Pharmaceuticals website. Retrieved on April 7, 2021.
- Xavier Castells, Lídia Blanco‐Silvente, and Ruth Cunill - Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults. Published online on August 9, 2018. Retrieved on April 7, 2021.
- Salima Punja, Larissa Shamseer, Lisa Hartling, Liana Urichuk, Ben Vandermeer, Jane Nikles, and Sunita Vohra - Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents. Published online on February 4, 2016. Retrieved on April 7, 2021.
- Sydney T. Osland, Thomas D.L. Steeves, and Tamara Pringsheim - Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders. Published online on June 26, 2018. Retrieved on April 7, 2021.
- Yu-Shu Huang and Ming-Horng Tsai - Long-Term Outcomes with Medications for Attention-Deficit Hyperactivity Disorder. Published in July 2011. Retrieved on April 7, 2021.
- L. Eugene Arnold, Paul Hodgkins, Hervé Caci, Jennifer Kahle, and Susan Young - Effect of Treatment Modality on Long-Term Outcomes in Attention-Deficit/Hyperactivity Disorder: A Systematic Review. Published online on February 25, 2015. Retrieved on April 7, 2021.
- Mydayis - dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine aspartate monohydrate, and amphetamine sulfate capsule, extended-release. Retrieved on April 7, 2021.
- NYU Langone Health. Study of the Duration and Efficacy of MYDAYIS on Adult ADHD Symptoms and Executive Function Throughout the Day Into the Early Evening (MYDAYIS). Published on May 10, 2019. Retrieved on April 7, 2021.
- Wigal T., Childress A., Frick G., Yan B., Wigal S., and Madhoo M. - Effects of SHP465 mixed amphetamine salts in adults with ADHD in a simulated adult workplace environment. Published in January 2018. Retrieved on April 7, 2021.
- Weisler R. H., Greenbaum M., Arnold V., Yu M., Yan B., Jaffee M., and Robertson B. - Efficacy and Safety of SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled, Forced-Dose Clinical Study. Published in August 2017. Retrieved on April 7, 2021.
- Thomas E. Brown, Emuella Flood, Phillip Sarocco, Norman Atkins, and Alexandra Khachatryan - Unmet Medication Coverage Needs among Adults with Attention-Deficit/Hyperactivity Disorder (ADHD). Published on September 15, 2017. Retrieved on April 7, 2021.
- Zhou Zhou, Zheng-yi Zhou, Sneha Kelkar, Jipan Xie, and Regina Grebla - Adherence, and Persistence on Long-Acting Monotherapy and Combination Therapy Among Commercially-Insured Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) in the US. Published in September 2017. Retrieved on April 7, 2021.
- Mydayis Side Effects -drugs.com. Retrieved on April 7, 2021.
- Mydayis Adverse Reactions -mydayis-pro.com. Retrieved on April 7, 2021.
- Mydayis - rxwiki.com. Retrieved on April 7, 2021.
- Clinical Update 2010: Use of Stimulant Medications in Pregnancy. womensmentalhealth.org. Posted on September 27, 2010. Retrieved on April 7, 2021.
- Pia Brandt Danborg, Anders Lykkemark Simonsen, and Peter C. Gøtzsche - Impaired reproduction after exposure to ADHD drugs: Systematic review of animal studies. Published online on September 2, 2017. Retrieved on April 7, 2021.
- ADHD Medication and Pregnancy - chadd.org. Retrieved on April 7, 2021.
- Concerta: ADHD Medication Overview - additudemag.com. Retrieved on April 7, 2021.
- Official Vyvanse website -vyvanse.com. Retrieved on April 7, 2021.
- Drug Approval Package -accessdata.fda.gov. Retrieved on April 7, 2021.
- David W. Goodman - Lisdexamfetamine Dimesylate (Vyvanse), A Prodrug Stimulant for Attention-Deficit/Hyperactivity Disorder. Published in May 2010. Retrieved on April 7, 2021.
- Vishal Madaan, Venkata Kolli, Durga P Bestha, and Manan J Shah - Update on optimal use of lisdexamfetamine in the treatment of ADHD. Published online on July 22, 2013. Retrieved on April 7, 2021.
- Adderall XR- dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine sulfate and amphetamine aspartate capsule, extended-release. dailymed.nlm.nih.gov. Retrieved on April 7, 2021.
- Leslie Briars and Timothy Todd - A Review of Pharmacological Management of Attention-Deficit/Hyperactivity Disorder. Published in June 2016. Retrieved on April 7, 2021.